APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alzheimer’s Therapeutic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alzheimer’s Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchAlzheimer’s Therapeutic Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Alzheimer’s Therapeutic Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Alzheimer’s Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alzheimer’s Therapeutic Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alzheimer’s Therapeutic Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Alzheimer’s Therapeutic market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alzheimer’s Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alzheimer’s Therapeutic include Takeda Pharmaceutical Company Ltd, Merck & Co, F. Hoffman Le Roche, Eli Lilly, Inc, Pfizer Inc, Novartis International AG, H. Lundbeck A/S, Biotie Therapies and Axovant Sciences Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alzheimer’s Therapeutic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alzheimer’s Therapeutic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alzheimer’s Therapeutic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alzheimer’s Therapeutic market size, projected growth trends, production technologies, key applications, and end-use industries.

Alzheimer’s Therapeutic Segment by Company

Takeda Pharmaceutical Company Ltd

Merck & Co

F. Hoffman Le Roche

Eli Lilly, Inc

Pfizer Inc

Novartis International AG

H. Lundbeck A/S

Biotie Therapies

Axovant Sciences Ltd

Astra Zeneca plc

Acadia Pharmaceuticals, Inc

Alzheimer’s Therapeutic Segment by Type

Rivastigmine

Galantamine Hydrobromide

Donepezil Hydrochloride

Memantine Hydrochloride

Alzheimer’s Therapeutic Segment by Application

Hospitals

Clinic

Other

Alzheimer’s Therapeutic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alzheimer’s Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alzheimer’s Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alzheimer’s Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alzheimer’s Therapeutic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alzheimer’s Therapeutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alzheimer’s Therapeutic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alzheimer’s Therapeutic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alzheimer’s Therapeutic Industry Trends Table 2. Alzheimer’s Therapeutic Industry Drivers Table 3. Alzheimer’s Therapeutic Industry Opportunities and Challenges Table 4. Alzheimer’s Therapeutic Industry Restraints Table 5. Global Alzheimer’s Therapeutic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alzheimer’s Therapeutic Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alzheimer’s Therapeutic Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Alzheimer’s Therapeutic Sales Market Share by Manufacturers Table 9. Global Alzheimer’s Therapeutic Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Alzheimer’s Therapeutic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alzheimer’s Therapeutic Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alzheimer’s Therapeutic Manufacturers, Product Type & Application Table 13. Global Alzheimer’s Therapeutic Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alzheimer’s Therapeutic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rivastigmine Table 17. Major Manufacturers of Galantamine Hydrobromide Table 18. Major Manufacturers of Donepezil Hydrochloride Table 19. Major Manufacturers of Memantine Hydrochloride Table 20. Global Alzheimer’s Therapeutic Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Alzheimer’s Therapeutic Sales by Type (2021-2026) & (k units) Table 22. Global Alzheimer’s Therapeutic Sales by Type (2027-2032) & (k units) Table 23. Global Alzheimer’s Therapeutic Sales Market Share by Type (2021-2026) Table 24. Global Alzheimer’s Therapeutic Sales Market Share by Type (2027-2032) Table 25. Global Alzheimer’s Therapeutic Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Alzheimer’s Therapeutic Revenue by Type (2021-2026) & (k units) Table 27. Global Alzheimer’s Therapeutic Revenue by Type (2027-2032) & (k units) Table 28. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2021-2026) Table 29. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Other Table 33. Global Alzheimer’s Therapeutic Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Alzheimer’s Therapeutic Sales by Application (2021-2026) & (k units) Table 35. Global Alzheimer’s Therapeutic Sales by Application (2027-2032) & (k units) Table 36. Global Alzheimer’s Therapeutic Sales Market Share by Application (2021-2026) Table 37. Global Alzheimer’s Therapeutic Sales Market Share by Application (2027-2032) Table 38. Global Alzheimer’s Therapeutic Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Alzheimer’s Therapeutic Revenue by Application (2021-2026) & (k units) Table 40. Global Alzheimer’s Therapeutic Revenue by Application (2027-2032) & (k units) Table 41. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2021-2026) Table 42. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2027-2032) Table 43. Global Alzheimer’s Therapeutic Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Alzheimer’s Therapeutic Sales by Region (2021-2026) & (k units) Table 45. Global Alzheimer’s Therapeutic Sales Market Share by Region (2021-2026) Table 46. Global Alzheimer’s Therapeutic Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Alzheimer’s Therapeutic Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 50. North America Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 51. Europe Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 53. Europe Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2027-2032) & (k units) Table 60. Global Alzheimer’s Therapeutic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Alzheimer’s Therapeutic Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Alzheimer’s Therapeutic Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2021-2026) Table 64. Global Alzheimer’s Therapeutic Revenue Market Share by Region (2027-2032) Table 65. Takeda Pharmaceutical Company Ltd Company Information Table 66. Takeda Pharmaceutical Company Ltd Business Overview Table 67. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product Portfolio Table 69. Takeda Pharmaceutical Company Ltd Recent Development Table 70. Merck & Co Company Information Table 71. Merck & Co Business Overview Table 72. Merck & Co Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck & Co Alzheimer’s Therapeutic Product Portfolio Table 74. Merck & Co Recent Development Table 75. F. Hoffman Le Roche Company Information Table 76. F. Hoffman Le Roche Business Overview Table 77. F. Hoffman Le Roche Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. F. Hoffman Le Roche Alzheimer’s Therapeutic Product Portfolio Table 79. F. Hoffman Le Roche Recent Development Table 80. Eli Lilly, Inc Company Information Table 81. Eli Lilly, Inc Business Overview Table 82. Eli Lilly, Inc Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly, Inc Alzheimer’s Therapeutic Product Portfolio Table 84. Eli Lilly, Inc Recent Development Table 85. Pfizer Inc Company Information Table 86. Pfizer Inc Business Overview Table 87. Pfizer Inc Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer Inc Alzheimer’s Therapeutic Product Portfolio Table 89. Pfizer Inc Recent Development Table 90. Novartis International AG Company Information Table 91. Novartis International AG Business Overview Table 92. Novartis International AG Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Novartis International AG Alzheimer’s Therapeutic Product Portfolio Table 94. Novartis International AG Recent Development Table 95. H. Lundbeck A/S Company Information Table 96. H. Lundbeck A/S Business Overview Table 97. H. Lundbeck A/S Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. H. Lundbeck A/S Alzheimer’s Therapeutic Product Portfolio Table 99. H. Lundbeck A/S Recent Development Table 100. Biotie Therapies Company Information Table 101. Biotie Therapies Business Overview Table 102. Biotie Therapies Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Biotie Therapies Alzheimer’s Therapeutic Product Portfolio Table 104. Biotie Therapies Recent Development Table 105. Axovant Sciences Ltd Company Information Table 106. Axovant Sciences Ltd Business Overview Table 107. Axovant Sciences Ltd Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Axovant Sciences Ltd Alzheimer’s Therapeutic Product Portfolio Table 109. Axovant Sciences Ltd Recent Development Table 110. Astra Zeneca plc Company Information Table 111. Astra Zeneca plc Business Overview Table 112. Astra Zeneca plc Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Astra Zeneca plc Alzheimer’s Therapeutic Product Portfolio Table 114. Astra Zeneca plc Recent Development Table 115. Acadia Pharmaceuticals, Inc Company Information Table 116. Acadia Pharmaceuticals, Inc Business Overview Table 117. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product Portfolio Table 119. Acadia Pharmaceuticals, Inc Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Alzheimer’s Therapeutic Distributors List Table 123. Alzheimer’s Therapeutic Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Alzheimer’s Therapeutic Product Image Figure 2. Global Alzheimer’s Therapeutic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alzheimer’s Therapeutic Market Size (2021-2032) & (US$ Million) Figure 4. Global Alzheimer’s Therapeutic Sales (2021-2032) & (k units) Figure 5. Global Alzheimer’s Therapeutic Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alzheimer’s Therapeutic Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rivastigmine Image Figure 9. Galantamine Hydrobromide Image Figure 10. Donepezil Hydrochloride Image Figure 11. Memantine Hydrochloride Image Figure 12. Global Alzheimer’s Therapeutic Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Alzheimer’s Therapeutic Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Alzheimer’s Therapeutic Sales Market Share by Type (2021-2032) Figure 15. Global Alzheimer’s Therapeutic Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Alzheimer’s Therapeutic Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Alzheimer’s Therapeutic Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Alzheimer’s Therapeutic Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Alzheimer’s Therapeutic Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Alzheimer’s Therapeutic Sales Market Share by Application (2021-2032) Figure 24. Global Alzheimer’s Therapeutic Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Alzheimer’s Therapeutic Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Alzheimer’s Therapeutic Revenue Market Share by Application (2021-2032) Figure 27. North America Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Alzheimer’s Therapeutic Sales Market Share by Country (2021-2032) Figure 29. U.S. Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Alzheimer’s Therapeutic Sales Market Share by Country (2021-2032) Figure 34. Germany Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Alzheimer’s Therapeutic Sales Market Share by Country (2021-2032) Figure 41. China Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Country (2021-2032) Figure 49. Brazil Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Alzheimer’s Therapeutic Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Alzheimer’s Therapeutic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Alzheimer’s Therapeutic Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Figure 60. North America Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Figure 62. Europe Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Alzheimer’s Therapeutic Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Alzheimer’s Therapeutic Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Alzheimer’s Therapeutic Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rivastigmine
  • Galantamine Hydrobromide
  • Donepezil Hydrochloride
  • Memantine Hydrochloride
Applications
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Merck & Co
  • F. Hoffman Le Roche
  • Eli Lilly, Inc
  • Pfizer Inc
  • Novartis International AG
  • H. Lundbeck A/S
  • Biotie Therapies
  • Axovant Sciences Ltd
  • Astra Zeneca plc
  • Acadia Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alzheimer’s Therapeutic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alzheimer’s Therapeutic Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alzheimer’s Therapeutic Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alzheimer’s Therapeutic Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alzheimer’s Therapeutic Market Dynamics
  1. 2.1 Alzheimer’s Therapeutic Industry Trends
  2. 2.2 Alzheimer’s Therapeutic Industry Drivers
  3. 2.3 Alzheimer’s Therapeutic Industry Opportunities and Challenges
  4. 2.4 Alzheimer’s Therapeutic Industry Restraints
3 Alzheimer’s Therapeutic Market by Manufacturers
  1. 3.1 Global Alzheimer’s Therapeutic Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alzheimer’s Therapeutic Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alzheimer’s Therapeutic Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alzheimer’s Therapeutic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alzheimer’s Therapeutic Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alzheimer’s Therapeutic Manufacturers, Product Type & Application
  7. 3.7 Global Alzheimer’s Therapeutic Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alzheimer’s Therapeutic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alzheimer’s Therapeutic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alzheimer’s Therapeutic Tier 1, Tier 2, and Tier 3
4 Alzheimer’s Therapeutic Market by Type
  1. 4.1 Alzheimer’s Therapeutic Type Introduction
  2. 4.1.1 Rivastigmine
  3. 4.1.2 Galantamine Hydrobromide
  4. 4.1.3 Donepezil Hydrochloride
  5. 4.1.4 Memantine Hydrochloride
  6. 4.2 Global Alzheimer’s Therapeutic Sales by Type
  7. 4.2.1 Global Alzheimer’s Therapeutic Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Alzheimer’s Therapeutic Sales by Type (2021-2032)
  9. 4.2.3 Global Alzheimer’s Therapeutic Sales Market Share by Type (2021-2032)
  10. 4.3 Global Alzheimer’s Therapeutic Revenue by Type
  11. 4.3.1 Global Alzheimer’s Therapeutic Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Alzheimer’s Therapeutic Revenue by Type (2021-2032)
  13. 4.3.3 Global Alzheimer’s Therapeutic Revenue Market Share by Type (2021-2032)
5 Alzheimer’s Therapeutic Market by Application
  1. 5.1 Alzheimer’s Therapeutic Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Alzheimer’s Therapeutic Sales by Application
  6. 5.2.1 Global Alzheimer’s Therapeutic Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alzheimer’s Therapeutic Sales by Application (2021-2032)
  8. 5.2.3 Global Alzheimer’s Therapeutic Sales Market Share by Application (2021-2032)
  9. 5.3 Global Alzheimer’s Therapeutic Revenue by Application
  10. 5.3.1 Global Alzheimer’s Therapeutic Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Alzheimer’s Therapeutic Revenue by Application (2021-2032)
  12. 5.3.3 Global Alzheimer’s Therapeutic Revenue Market Share by Application (2021-2032)
6 Global Alzheimer’s Therapeutic Sales by Region
  1. 6.1 Global Alzheimer’s Therapeutic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alzheimer’s Therapeutic Sales by Region (2021-2032)
  3. 6.2.1 Global Alzheimer’s Therapeutic Sales by Region (2021-2026)
  4. 6.2.2 Global Alzheimer’s Therapeutic Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alzheimer’s Therapeutic Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alzheimer’s Therapeutic Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alzheimer’s Therapeutic Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alzheimer’s Therapeutic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alzheimer’s Therapeutic Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alzheimer’s Therapeutic Revenue by Region
  1. 7.1 Global Alzheimer’s Therapeutic Revenue by Region
  2. 7.1.1 Global Alzheimer’s Therapeutic Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alzheimer’s Therapeutic Revenue by Region (2021-2026)
  4. 7.1.3 Global Alzheimer’s Therapeutic Revenue by Region (2027-2032)
  5. 7.1.4 Global Alzheimer’s Therapeutic Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alzheimer’s Therapeutic Revenue (2021-2032)
  8. 7.2.2 North America Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alzheimer’s Therapeutic Revenue (2021-2032)
  11. 7.3.2 Europe Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alzheimer’s Therapeutic Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alzheimer’s Therapeutic Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alzheimer’s Therapeutic Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company Ltd
  2. 8.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 8.2 Merck & Co
  8. 8.2.1 Merck & Co Company Information
  9. 8.2.2 Merck & Co Business Overview
  10. 8.2.3 Merck & Co Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co Alzheimer’s Therapeutic Product Portfolio
  12. 8.2.5 Merck & Co Recent Developments
  13. 8.3 F. Hoffman Le Roche
  14. 8.3.1 F. Hoffman Le Roche Company Information
  15. 8.3.2 F. Hoffman Le Roche Business Overview
  16. 8.3.3 F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 F. Hoffman Le Roche Alzheimer’s Therapeutic Product Portfolio
  18. 8.3.5 F. Hoffman Le Roche Recent Developments
  19. 8.4 Eli Lilly, Inc
  20. 8.4.1 Eli Lilly, Inc Company Information
  21. 8.4.2 Eli Lilly, Inc Business Overview
  22. 8.4.3 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly, Inc Alzheimer’s Therapeutic Product Portfolio
  24. 8.4.5 Eli Lilly, Inc Recent Developments
  25. 8.5 Pfizer Inc
  26. 8.5.1 Pfizer Inc Company Information
  27. 8.5.2 Pfizer Inc Business Overview
  28. 8.5.3 Pfizer Inc Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Inc Alzheimer’s Therapeutic Product Portfolio
  30. 8.5.5 Pfizer Inc Recent Developments
  31. 8.6 Novartis International AG
  32. 8.6.1 Novartis International AG Company Information
  33. 8.6.2 Novartis International AG Business Overview
  34. 8.6.3 Novartis International AG Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis International AG Alzheimer’s Therapeutic Product Portfolio
  36. 8.6.5 Novartis International AG Recent Developments
  37. 8.7 H. Lundbeck A/S
  38. 8.7.1 H. Lundbeck A/S Company Information
  39. 8.7.2 H. Lundbeck A/S Business Overview
  40. 8.7.3 H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 H. Lundbeck A/S Alzheimer’s Therapeutic Product Portfolio
  42. 8.7.5 H. Lundbeck A/S Recent Developments
  43. 8.8 Biotie Therapies
  44. 8.8.1 Biotie Therapies Company Information
  45. 8.8.2 Biotie Therapies Business Overview
  46. 8.8.3 Biotie Therapies Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biotie Therapies Alzheimer’s Therapeutic Product Portfolio
  48. 8.8.5 Biotie Therapies Recent Developments
  49. 8.9 Axovant Sciences Ltd
  50. 8.9.1 Axovant Sciences Ltd Company Information
  51. 8.9.2 Axovant Sciences Ltd Business Overview
  52. 8.9.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Axovant Sciences Ltd Alzheimer’s Therapeutic Product Portfolio
  54. 8.9.5 Axovant Sciences Ltd Recent Developments
  55. 8.10 Astra Zeneca plc
  56. 8.10.1 Astra Zeneca plc Company Information
  57. 8.10.2 Astra Zeneca plc Business Overview
  58. 8.10.3 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Astra Zeneca plc Alzheimer’s Therapeutic Product Portfolio
  60. 8.10.5 Astra Zeneca plc Recent Developments
  61. 8.11 Acadia Pharmaceuticals, Inc
  62. 8.11.1 Acadia Pharmaceuticals, Inc Company Information
  63. 8.11.2 Acadia Pharmaceuticals, Inc Business Overview
  64. 8.11.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product Portfolio
  66. 8.11.5 Acadia Pharmaceuticals, Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alzheimer’s Therapeutic Value Chain Analysis
  2. 9.1.1 Alzheimer’s Therapeutic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alzheimer’s Therapeutic Production Mode & Process
  6. 9.2 Alzheimer’s Therapeutic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alzheimer’s Therapeutic Distributors
  9. 9.2.3 Alzheimer’s Therapeutic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst